Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the induced pluripotent stem cell (ipsc) market grown over the years?

The market size for induced pluripotent stem cells (iPSC) has seen a swift expansion in the past few years. It is projected to rise from $3.3 billion in 2024 to $3.67 billion in 2025 with a compound annual growth rate (CAGR) of 11.3%. The substantial growth during the historic period is attributed to factors like increased healthcare spending, elevated funding levels, burgeoning awareness about the medicinal benefits of stem cell products, the application of IPSC for drug discovery, the surging demand for personalized medicine, and the cost-effectiveness of IPSC in drug discovery.

What Is the forecasted market size and growth rate for the induced pluripotent stem cell (ipsc) market?

The market size for the home theatre systems is slated to experience a considerable spike in the upcoming years, reaching a value of $95.46 billion in 2029 with a compound annual growth rate (CAGR) of 20.8%. The surge in this period is anticipated due to factors like the shift towards premium and sophisticated features, the rising trend in home makeovers and designing, increased use of streaming services and content consumption, compatibility with smart home automation and evolving customer lifestyles and tastes. Key trends during this projection period will be sleek and visually appealing designs, partnerships with streaming platforms, customizable and module-based components, the rise in popularity of soundbars, and the incorporation of AI and machine learning.

Get your induced pluripotent stem cell (ipsc) market report here!

https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report

What are the major factors driving growth in the induced pluripotent stem cell (ipsc) market?

The growth of the induced pluripotent stem cell market is being majorly propelled by a surge in the prevalence of chronic diseases. Induced pluripotent stem cells, which can be obtained from the tissues of a child or an adult and genetically altered to act like embryonic stem cells, offer a potential treatment for chronic diseases like heart disease, cancer, stroke, and diabetes. A study conducted by Partnership to Fight Chronic Disorder (PFCD) revealed that nearly 45% of the 133 million Americans, had at least one chronic disorder. Furthermore, it was projected that around 1.7 million deaths in the USA, or seven out of ten, are attributed to chronic diseases which could be managed with treatments involving induced pluripotent stem cells. This increase in chronic disease incidences is contributing to an increased demand in the induced pluripotent stem cell treatment market.

What key areas define the segmentation of the global induced pluripotent stem cell (ipsc) Market?

The induced pluripotent stem cell (iPSC) market covered in this report is segmented –

1) By Derived Cell Type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cell Types

2) By Application: Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Cell And Gene Therapy

3) By End-User: Hospitals, Research Laboratories

Subsegments:

1) By Hepatocytes: iPSC-Derived Liver Cells For Drug Toxicity Testing, Disease Modeling And Regenerative Therapies

2) By Fibroblasts: iPSC-Derived Skin Cells For Wound Healing And Tissue Repair, Fibroblast-Based Disease Research

3) By Keratinocytes: iPSC-Derived Skin Cells For Dermatological Research, Skin Regeneration Therapies

4) By Amniotic Cells: iPSC-Derived Cells For Prenatal Research, Amniotic Fluid-Based Regenerative Applications

5) By Other Derived Cell Types: Neurons For Neurological Disease Modeling, Cardiomyocytes For Heart Disease Studies, Endothelial Cells For Vascular Research

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2515&type=smp

What are the top market players propelling the growth of the induced pluripotent stem cell (ipsc) industry?

Major companies operating in the induced pluripotent stem cell (iPSC) market include FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc), Thermo Fisher Scientific, Inc, Takara Bio, Inc, Lonza Group AG, Astellas Pharma Inc, ViaCyte, Inc, Ncardia, REPROCELL USA, Inc, Japan Tissue Engineering Co., Ltd, Merck KGaA, Cynata Therapeutics Limited, Dainippon Sumitomo Pharma, Shenzhen Bioscience, Shanghai Cell Therapy Group, Car-T Bio, JW therapeutics, Fosun Kite Biotechnology, Shanghai UniCar Therapy, Takaria Bio, SEED Biosciences SA, Cellerix, CellGenix, NsGene, TiGenix, Renuron Group, Smart Cells, Genenta Science, Biocad Rf, MSD, Pfizer, Roche, Pharmasyntez, Selvita, Mabion, Pure Biologics, OncoArendi Therapeutics, Proteon Pharmaceuticals, GlaxoSmithKline, Parexel, Bayer, Fate Therapeutics, Athersys, BrainStorm Cell Therapeutics, Cellular Biomedicine Group, Pluristem Therapeutics, Gamida Cell, VistaGen Therapeutics, Caladrius Biosciences, BioCanRx, CellCAN, CCRM, C3i, BioCells Argentina, Stem Cells, Royan Stem Cell Technology Co., Next BioSciences, CryoSave, BioHeart

What are the key trends shaping the future of the induced pluripotent stem cell (ipsc) market?

Firms within the Induced Pluripotent stem cell market are seeking to establish strategic alliances and partnerships that can assist them in penetrating new territories and broadening their product range. To illustrate, Bristol Myers Squibb and Century Therapeutics entered into a strategic alliance in January 2022 to develop IPSC-derived allogenic cell therapies aimed at curing acute myeloid leukemia and multiple myeloma. Subsequently in May 2022, Evotec and Sernova formed a strategic partnership to create an IPSC-based beta cell replacement therapy meant for the treatment of both type 1 and type 2 diabetes.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2515

What regions are dominating the induced pluripotent stem cell (ipsc) market growth?

North America was the largest region in the induced pluripotent stem cell (IPSC) market in 2024. Western Europe was the second largest region in the global induced pluripotent stem cell (IPSC) market share. The regions covered in the induced pluripotent stem cell (IPSC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Stem Cell/Cord Blood Banking Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report

Stem Cell Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report

Cell Culture Consumables And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-culture-consumables-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: